Therefore all were selected for further functional analysis together with BACH2 and PRDM1, which had been implicated as TSG in lymphoid tumours [6, 12] and are positioned within the 6q15-6q21 deletion hot-spot (Fig. 1B). The gene discussed is BACH2; the disease is lymphoid neoplasm.